Hoe kunnen we doorbraken binnen het fundamenteel-biomedische onderzoek beter vertalen naar de ontwikkeling van nieuwe medicijnen?

Alle bijbehorende onderzoeksagenda's

Ageing
LUMC
Anemie
Sanquin
Biomedical Technology
UT
Bioscience: the Science Base of Health
LEI
Cognition, Socio-economic Behaviour and Neuro­science
UvA
Elucidating malignant transformation
RUG
Enabling technologies
NFU
Fundamentals of Natural Science
UvA
Genomics
AMC
Health
TUD
Health & behavioural economics
EUR
Health care innovation
MUMC
Healthcare improvement science
Radboud UMC
Human Health
UvA
Human Health & Life Sciences
VU
Immunity, infection and tolerance
LUMC
Immuundeficiëntie en Veroudering
Sanquin
Infection & immunity
UMCU
Innovation in health strategy and quality of care
LUMC
Kanker
Sanquin
Klinische neurowetenschappen
KNAW: Spinoza Centre for Neuroimaging
Law and Governance
RUG
Life Science
CWI
Medical Delta
Leiden-Delft-Erasmus
Medical Integromics
AMC
Methoden en statistiek
KNAW: Spinoza Centre for Neuroimaging
Molecular Life & Health
RUG
Personalised medicine
RUN
Predictive Health Technologies
TNO
Quality of Life
UM
Regenerative medicine & stem cells
UMCU
Systems Biology
AMC
Translational Drug Discovery and Development
LEI
Translational neuroscience
LUMC
Transnational Research
AMC
Vascular and regenerative medicine
LUMC